SEI Investments’s Immunocore IMCR Stock Holding History

SEI Investments’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Sell	39,213 -22,047	-36%	-$652K	﹤0.01%	2191
2026 Q1	$1.85M	Buy	61,260 +10,923	+22%	+$353K	﹤0.01%	2049
2025 Q4	$1.75M	Buy	50,337 +15,352	+44%	+$542K	﹤0.01%	1920
2025 Q3	$1.27M	Buy	34,985 +3,651	+12%	+$124K	﹤0.01%	1882
2025 Q2	$983K	Buy	31,334 +20,598	+192%	+$640K	﹤0.01%	1936
2025 Q1	$319K	Buy	+10,736	New	+$322K	﹤0.01%	2317
2024 Q2	–	Sell	-5,807	Closed	-$377K	–	2684
2024 Q1	$377K	Buy	5,807 +107	+2%	+$7.34K	﹤0.01%	2218
2023 Q4	$389K	Sell	5,700 -22,507	-80%	-$1.17M	﹤0.01%	2212
2023 Q3	$1.46M	Buy	28,207 +620	+2%	+$36.7K	﹤0.01%	1738
2023 Q2	$1.65M	Sell	27,587 -14,267	-34%	-$814K	﹤0.01%	1703
2023 Q1	$2.07M	Buy	41,854 +29,390	+236%	+$1.65M	﹤0.01%	1601
2022 Q4	$711K	Sell	12,464 -16,259	-57%	-$915K	﹤0.01%	1883
2022 Q3	$1.35M	Buy	+28,723	New	+$1.37M	﹤0.01%	1698

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SEI Investments's IMCR Position: Q2 2026 in Review

SEI Investments reduced its Immunocore (IMCR) stake by 36% in Q2 2026, selling an estimated $652K and leaving 39,213 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

SEI Investments first reported a position in IMCR in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.07M in Q1 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

SEI Investments held 39,213 shares of Immunocore worth $1.25M as of Q2 2026.
SEI Investments sold 22,047 Immunocore shares in Q2 2026, an estimated $652K.
Immunocore made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2191 holding.
SEI Investments first reported a position in Immunocore in Q3 2022 and has held it in 13 quarters since.
SEI Investments's Immunocore position peaked at $2.07M in Q1 2023.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.